CD274 and lung carcinoma: To our best knowledge, this is the first prospective study that longitudinally examined cachexia-related circulating cytokines, both at baseline and during treatment, and assessed their role in predicting the clinical outcomes of lung cancer patients treated with PD-1/PD-L1 blockade.